Skip to content

Author

Ling-Ling Li

We have 5 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Iron, Copper, and Zinc Dyshomeostasis in Cardiovascular and Cerebrovascular Diseases: Redox Mechanisms, Evidence Levels, and Translational Prospects

Iron (Fe), copper (Cu), and zinc (Zn) are essential trace elements for cardiovascular and cerebrovascular homeostasis, acting as enzymatic cofactors in energy metabolism and antioxidant defence. However, disruption of metal homeostasis can amplify oxidative injury through direct Fe/Cu redox chemistry or indirect Zn-dep...

Kai Wang, Yong-Chao Liu, Xiao-Min Li et al. · 0 citations
Meta-analysis Open access Sep 2026

Dose-response and time-course effects of ecnoglutide in type 2 diabetes: a systematic review and meta-analysis of efficacy

Dose-response analysis showed that ecnoglutide exhibited a clear dose-dependent relationship for HbA1c, FPG, and body weight at doses ranging from 0.4 to 1.2 mg, while PPG was less affected by dose.

Yi-Xuan Feng, Chang-Xin Sun, Xiao-Ya Li et al. · 0 citations
Review Open access Sep 2026

Apolipoprotein B in cardiovascular risk assessment: beyond traditional lipid markers

Apolipoprotein B (ApoB) serves as the structural backbone of triglyceride (TG)-rich lipoproteins and low-density lipoprotein (LDL) particles and plays a key role in lipid transport. A growing body of evidence indicates that circulating ApoB levels are closely associated with the development of cardiovascular diseases s...

Ling-Ling Li, Yi-Xuan Feng, Xiao-Ya Li et al. · 0 citations
Review Open access Sep 2026

Polydatin Delivery Systems and Nanomedicine: Pharmacology, Preclinical Evidence, and Translation

Background: Polydatin has shown anti-inflammatory, antioxidant, and cytoprotective effects in preclinical studies. Its development is limited by low oral bioavailability, extensive metabolism, and poorly defined tissue exposure. Objectives: This review summarizes the pharmacology and delivery systems of polydatin, dist...

Xiao-Ya Li, Ling-Ling Li, Yong-Fang Yuan et al. · 0 citations
Open access Aug 2026

Polydatin in combination with hawthorn flavonoids alleviates atherosclerosis by inhibiting mitochondrial division through the YTHDF2-DRP1 axis.

PH exerts a protective effect on HUVECs and prevents AS by regulating the YTHDF2/DRP1 axis to restore mitochondrial homeostasis, thereby providing a novel therapeutic approach for AS.

Yu-Juan Li, Xiao-Nan Zhang, Sheng-Jie Yang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.